Insights
Search Results
Client Highlights
2.19.26
Firm Advises Ekso Bionics on Contribution and Exchange Agreement with Applied Digital
On February 15, 2026, Applied Digital entered into a Contribution and Exchange Agreement to combine its cloud subsidiary, Applied Digital Cloud Corporation, with Ekso Bionics. At closing, Ekso will operate as the parent of the combined company and will change its name to ChronoScale Company. Wilson Sonsini Goodrich & Rosati is advising Ekso on the transaction.
Client Highlights
2.06.26
Wilson Sonsini Advises PacBio on Sale of Short-Read DNA Sequencing Assets
On February 2, 2026, PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announced the completion of the sale of select intellectual property and other assets related to PacBio’s short-read DNA sequencing technology and related clustering, sequencing reagent, and detection technologies to Illumina, Inc. PacBio received approximately $50 million in cash proceeds from the transaction. Wilson Sonsini Goodrich & Rosati advised PacBio on the transaction.
Client Highlights
2.02.26
Wilson Sonsini Advises ESS Tech on $15 Million Registered Direct Offering
On January 29, 2026, ESS Tech, a leading manufacturer of long-duration energy storage systems (LDES) for commercial and utility-scale applications, announced that it has entered into definitive agreements in a registered direct offering with institutional investors for the purchase and sale of approximately $15 million of shares of common stock and pre-funded warrants at a price of $1.75 per share of common stock, which price was a premium to the closing price on January 28, 2026. Wilson Sonsini Goodrich & Rosati advised ESS Tech on the transaction.
Client Highlights
4.22.25
Wilson Sonsini Advises Altruist on $152 Million Series F Financing
On April 22, 2025, Altruist, the modern custodian for RIAs, announced $152 million in Series F funding led by GIC, a global institutional investor. Salesforce Ventures, Geodesic Capital, Baillie Gifford, Carson Family Office, ICONIQ Growth, and a select group of additional partners also participated. The round values the company at approximately $1.9 billion. Wilson Sonsini Goodrich & Rosati advised Altruist on the transaction.
The Series F funding follows a landmark year. In 2024, Altruist launched a suite of new products, including a high-yield cash account, automated and scalable tax management tools, and a fully digital native fixed-income trading experience. The company achieved triple-digit growth in key metrics such as revenue, brokerage accounts, and advisors served.
The Wilson Sonsini team that advised Altruist on the transaction included:
The Series F funding follows a landmark year. In 2024, Altruist launched a suite of new products, including a high-yield cash account, automated and scalable tax management tools, and a fully digital native fixed-income trading experience. The company achieved triple-digit growth in key metrics such as revenue, brokerage accounts, and advisors served.
The Wilson Sonsini team that advised Altruist on the transaction included:
Client Highlights
5.05.23
Wilson Sonsini Advises Via on Its Acquisition of MPEG LA
On May 2, 2023, collaborative licensing leader Via Licensing Corporation (Via) announced its acquisition of MPEG LA forming Via Licensing Alliance LLC (Via LA). The deal created the largest patent pool administrator in the consumer electronics industry. Wilson Sonsini Goodrich & Rosati advised Via on the deal.
Client Highlights
4.17.23
Firm Advises Altruist on $112 Million Series D Financing
On April 12, 2023, registered investment advisor custodian Altruist announced that it has raised $112 million in a Series D round of funding. The financing was led by Insight Partners, new investor Adams Street Partners, and included support from existing investors. Industry leaders Bill McNabb, Ron Carson, and Marty Bicknell also participated in the round. Wilson Sonsini Goodrich & Rosati advised Altruist on the transaction.
Client Highlights
1.10.23
Wilson Sonsini Advises Carbon Health on $100 Million Series D Investment Round
On January 9, 2023, Carbon Health, a hybrid healthcare company that combines expert care with proprietary technology for easy everyday health, announced that it has received $100 million from CVS Health Ventures, CVS Health’s corporate venture capital platform, as part of an initial close of its Series D round. The funding enables the primary care provider to scale its Connective Care model into new geographies, sign new value-based care arrangements, and invest in technology as it aims to be a national leader in primary and urgent care. Wilson Sonsini Goodrich & Rosati advised Carbon Health on the transaction.
Client Highlights
11.04.22
Firm Advises Bakkt on Acquisition of Apex Crypto
On November 3, 2022, digital asset platform Bakkt Holdings Inc. announced the acquisition of Apex Crypto LLC from Apex Fintech Solutions Inc. in a move that will bolster Bakkt’s cryptocurrency product offering and expand its footprint into new client verticals. Wilson Sonsini Goodrich & Rosati advised Bakkt on the deal.
Client Highlights
4.30.21
Firm Advises Sonder on Business Combination with Gores Metropoulos II SPAC
On April 30, 2021, Sonder Holdings, a leading next-generation hospitality company that is redefining the guest experience, and Gores Metropoulos II, Inc., a special purpose acquisition company (SPAC) sponsored by an affiliate of The Gores Group, LLC and by an affiliate of Dean Metropoulos of Metropoulos & Co., announced that they have entered into a definitive agreement to combine. The technology-driven hospitality business is expected to have a pro forma enterprise value of $2.2 billion and over $700 million of net cash at closing. Wilson Sonsini Goodrich & Rosati is representing Sonder in the transaction.
The business combination includes $650 million of cash proceeds from Gores Metropoulos II before expenses, including a fully committed PIPE of $200 million from top-tier institutional investors, including Fidelity Management & Research Company LLC, funds and accounts managed by BlackRock, Atreides Management, LP, entities affiliated with Moore Capital Management, Principal Global Investors, LLC, and Senator Investment Group. The proceeds from the business combination, which has been unanimously approved by the boards of directors of GM II and Sonder and is expected to close in the second half of 2021, will be used to continue global growth and expansion and increase investments in technology to drive an elevated guest experience.
The business combination includes $650 million of cash proceeds from Gores Metropoulos II before expenses, including a fully committed PIPE of $200 million from top-tier institutional investors, including Fidelity Management & Research Company LLC, funds and accounts managed by BlackRock, Atreides Management, LP, entities affiliated with Moore Capital Management, Principal Global Investors, LLC, and Senator Investment Group. The proceeds from the business combination, which has been unanimously approved by the boards of directors of GM II and Sonder and is expected to close in the second half of 2021, will be used to continue global growth and expansion and increase investments in technology to drive an elevated guest experience.
Client Highlights
3.24.21
Wilson Sonsini Provides Counsel to New Consumer-Directed Health and Care Platform Transcarent
San Francisco-based Transcarent is a new consumer-directed health and care platform for employees of self-insured employers and their families. The company was created to improve the quality and value of care in America by providing a new health and care experience for employees and their families by providing greater control over their healthcare decisions and enabling them to share in the financial benefits of those decisions.
On March 18, 2021, Transcarent announced that Glen Tullman has added the role of CEO to his role of executive chairman of the company. In October 2020, Transcarent closed a $40 million Series A financing round led by General Catalyst (Hemant Taneja) and 7wire Ventures (Lee Shapiro), with participation from Alta Partners and Jove Equity Partners. In connection with the Series A financing, Transcarent also acquired BridgeHealth, the industry-leading provider of surgical advocacy and centers of excellence (COE) programs for large, self-insured organizations and their members. Transcarent and these transactions were recently profiled in this Forbes article.
Wilson Sonsini Goodrich & Rosati advised Transcarent on both the Series A financing and the acquisition of BridgeHealth. In addition, the firm previously represented Livongo—a company founded by Mr. Tullman—in its 2019 IPO, which was the largest consumer digital health IPO in history.
The Wilson Sonsini team that advised Transcarent on the Series A financing and associated acquisition of BridgeHealth includes:
On March 18, 2021, Transcarent announced that Glen Tullman has added the role of CEO to his role of executive chairman of the company. In October 2020, Transcarent closed a $40 million Series A financing round led by General Catalyst (Hemant Taneja) and 7wire Ventures (Lee Shapiro), with participation from Alta Partners and Jove Equity Partners. In connection with the Series A financing, Transcarent also acquired BridgeHealth, the industry-leading provider of surgical advocacy and centers of excellence (COE) programs for large, self-insured organizations and their members. Transcarent and these transactions were recently profiled in this Forbes article.
Wilson Sonsini Goodrich & Rosati advised Transcarent on both the Series A financing and the acquisition of BridgeHealth. In addition, the firm previously represented Livongo—a company founded by Mr. Tullman—in its 2019 IPO, which was the largest consumer digital health IPO in history.
The Wilson Sonsini team that advised Transcarent on the Series A financing and associated acquisition of BridgeHealth includes:
Client Highlights
9.03.20
Wilson Sonsini Advises QuantumScape in Merger with Kensington Capital Acquisition Corp.
On September 3, 2020, QuantumScape Corporation, a developer of next generation solid-state lithium-metal batteries for use in electric vehicles, and Kensington Capital Acquisition Corp., a special purpose acquisition company (SPAC), announced a definitive agreement for a business combination that would result in QuantumScape becoming a publicly listed company. The combined company will be named QuantumScape and is expected to remain listed on the NYSE. Wilson Sonsini Goodrich & Rosati is advising QuantumScape in the transaction.